ProteinQure Inc.

Profile

ProteinQure has built the best computational platform for designing peptides for extra-cellular targets. Its lead program is a peptide drug conjugate for TOP1 resistant solid tumors and is in Phase I and at the best hospitals in North America and has begun dosing. Its platform has been validated (in-vivo and with unprecedented in-vitro characteristics) with four top 25 pharma companies in their experimental assays. ProteinQure is the only computational platform capable of designing peptides with the full complement of non-canonical amino acids, so that our peptides are 100x better than natural peptide ligands. For its own internal programs Protein Qure uses the novel peptides to help deliver payloads in a tissue specific manner. Peptides are ideal for delivery of different payloads like radioisotopes and gene therapy since they are tissue specific and easier to manufacture. ProteinQure also has exciting in-vivo POC for siRNA delivery to CNS.

Website

proteinqure.com

Contact


Event details

Date: November 9 - 11, 2026

Event contact

Patricia Cosgrove
Senior International Market Consultant
U.S.A. & Europe

Participants

<?php global $lang_id; switch ($lang_id) { case "fr": echo 'Total de 24'; break; case "pt-br": echo 'Total de 24'; break; case "es": echo 'Total de 24'; break; case "ja": echo '24 合計'; break; case "ko": echo '24 총계'; break; case "en": default: echo '24 in total'; break; } ?>